[Thrombolytic therapy in acute myocardial infarct]

Med Klin (Munich). 1992 Feb 15;87(2):64-9.
[Article in German]
No abstract available

Publication types

  • Comparative Study
  • Consensus Development Conference
  • Review

MeSH terms

  • Anistreplase / therapeutic use
  • Dose-Response Relationship, Drug
  • Enzyme Precursors / therapeutic use
  • Fibrinolytic Agents / administration & dosage
  • Fibrinolytic Agents / therapeutic use*
  • Humans
  • Myocardial Infarction / drug therapy*
  • Plasminogen Activators / therapeutic use
  • Recombinant Proteins
  • Shock, Cardiogenic / drug therapy
  • Streptokinase / therapeutic use
  • Tissue Plasminogen Activator / therapeutic use
  • Urokinase-Type Plasminogen Activator / therapeutic use

Substances

  • Enzyme Precursors
  • Fibrinolytic Agents
  • Recombinant Proteins
  • Anistreplase
  • Streptokinase
  • Plasminogen Activators
  • Tissue Plasminogen Activator
  • Urokinase-Type Plasminogen Activator
  • saruplase